Startseite The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7

  • Siwei Liu , Huajiang Lei , Fangyuan Luo , Yilin Li und Lan Xie ORCID logo EMAIL logo
Veröffentlicht/Copyright: 19. Februar 2018

Abstract

This study aimed at investigating the biological functions of long non-coding RNAs (lncRNAs) hox transcript antisense intergenic RNA (HOTAIR) in resistant ovarian cancer cells, exploring the regulation effect of HOTAIR on HOXA7, and investigating their influence on the chemosensitivity of ovarian cancer cells. Quantitative real-time polymerase chain reaction (qRT-PCR) was applied for the verification of HOTAIR expression in resistant and sensitive groups. How HOTAIR downregulation affected cell proliferation, migration and invasion, and apoptosis were determined using the MTT assay and the colony formation assay, the Transwell assay and flow cytometry analysis, respectively. Immunohistochemistry was used to inspect the protein expression of HOXA7 in resistant and sensitive ovarian cancer tissues. The regulation relationship between HOTAIR and HOXA7 was investigated by qRT-PCR and Western blot. The effect of HOTAIR and HOXA7 on tumor growth was confirmed by the tumor xenograft model of nude mice. By knocking down HOXA7, HOTAIR downregulation restrained the ovarian cancer deterioration in functional experiments. Silencing of HOTAIR and HOXA7 could effectively inhibit tumor growth and increase chemosensitivity of ovarian tumors in nude mice. Downregulation of HOTAIR negatively affected the survival and activity of resistant ovarian cancer cells, and suppressed the expression of HOXA7. Silencing of HOTAIR and HOXA7 could increase the chemosensitivity of ovarian cancer cells, thus suppressing tumor development.

Acknowledgments

This study was supported by the 2014 Ph.D. Program Foundation of Sichuan Provincial People’s Hospital (No. 30305030832).

References

Bhatlekar, S., Fields, J.Z., and Boman, B.M. (2014). HOX genes and their role in the development of human cancers. J. Mol. Med. (Berl.) 92, 811–823.10.1007/s00109-014-1181-ySuche in Google Scholar

Coleman, R.L., Brady, M.F., Herzog, T.J., Sabbatini, P., Armstrong, D.K., Walker, J.L., Kim, B.G., Fujiwara, K., Tewari, K.S., O’Malley, D.M., et al. (2017). Bevacizumab and paclitaxel-carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 18, 779–791.10.1016/S1470-2045(17)30279-6Suche in Google Scholar

Cui, L., Xie, X.Y., Wang, H., Chen, X.L., Liu, S.L., and Hu, L.N. (2013). [Expression of long non-coding RNA HOTAIR mRNA in ovarian cancer]. Sichuan Da Xue Xue Bao Yi Xue Ban 44, 57–59. [in Chinese]Suche in Google Scholar

Dong, L. and Hui, L. (2016). HOTAIR promotes proliferation, migration, and invasion of ovarian cancer SKOV3 cells through regulating PIK3R3. Med. Sci. Monit. 22, 325–331.10.12659/MSM.894913Suche in Google Scholar PubMed PubMed Central

Guo, Q., Jiang, Q., Liu, W., and Bai, Y. (2016). All-trans retinoic acid inhibits HOXA7 expression in leukemia cell NB4. Cell. Mol. Biol. (Noisy-le-Grand) 62, 63–66.Suche in Google Scholar

Gustafsson-Lutz, A., Back, T., Aneheim, E., Hultborn, R., Palm, S., Jacobsson, L., Morgenstern, A., Bruchertseifer, F., Albertsson, P., and Lindegren, S. (2017). Therapeutic efficacy of α-radioimmunotherapy with different activity levels of the 213Bi-labeled monoclonal antibody MX35 in an ovarian cancer model. EJNMMI Res. 7, 38.10.1186/s13550-017-0283-2Suche in Google Scholar PubMed PubMed Central

Hu, X., Feng, Y., Zhang, D., Zhao, S.D., Hu, Z., Greshock, J., Zhang, Y., Yang, L., Zhong, X., Wang, L.P., et al. (2014). A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell 26, 344–357.10.1016/j.ccr.2014.07.009Suche in Google Scholar PubMed PubMed Central

Huang, S.C., Lin, J.K., Lin, T.C., Chen, W.S., Yang, S.H., Wang, H.S., Lan, Y.T., Lin, C.C., Jiang, J.K., and Chang, S.C. (2015). Concordance of carcinoembryonic antigen ratio and response evaluation criteria in solid tumors as prognostic surrogate indicators of metastatic colorectal cancer patients treated with chemotherapy. Ann. Surg. Oncol. 22, 2262–2268.10.1245/s10434-014-4228-ySuche in Google Scholar PubMed

Ke, D., Li, H., Zhang, Y., An, Y., Fu, H., Fang, X., and Zheng, X. (2017). The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer. Oncotarget 8, 21516–21525.10.18632/oncotarget.15628Suche in Google Scholar PubMed PubMed Central

Kelly, Z., Moller-Levet, C., McGrath, S., Butler-Manuel, S., Kavitha Madhuri, T., Kierzek, A.M., Pandha, H., Morgan, R., and Michael, A. (2016). The prognostic significance of specific HOX gene expression patterns in ovarian cancer. Int. J. Cancer 139, 1608–1617.10.1002/ijc.30204Suche in Google Scholar PubMed

Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., and Safe, S. (2013). HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene 32, 1616–1625.10.1038/onc.2012.193Suche in Google Scholar PubMed PubMed Central

Kim, J.W., Kim, J.Y., Kim, J.E., Kim, S.K., Chung, H.T., and Park, C.K. (2014). HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines. Genes Cancer 5, 165–174.10.18632/genesandcancer.16Suche in Google Scholar PubMed PubMed Central

Kim, H.J., Lee, D.W., Yim, G.W., Nam, E.J., Kim, S., Kim, S.W., and Kim, Y.T. (2015). Long non-coding RNA HOTAIR is associated with human cervical cancer progression. Int. J. Oncol. 46, 521–530.10.3892/ijo.2014.2758Suche in Google Scholar PubMed PubMed Central

Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011). Long noncoding RNA HOTAIR regulates polycomb-dependent chromatin modification and is associated with poor prognosis in colorectal cancers. Cancer Res. 71, 6320–6326.10.1158/0008-5472.CAN-11-1021Suche in Google Scholar PubMed

Li, Y., Yang, X.H., Fang, S.J., Qin, C.F., Sun, R.L., Liu, Z.Y., Jiang, B.Y., Wu, X., and Li, G. (2015). HOXA7 stimulates human hepatocellular carcinoma proliferation through cyclin E1/CDK2. Oncol. Rep. 33, 990–996.10.3892/or.2014.3668Suche in Google Scholar PubMed

Li, J., Yang, S., Su, N., Wang, Y., Yu, J., Qiu, H., and He, X. (2016). Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt/β-catenin pathway in human ovarian cancer. Tumour Biol. 37, 2057–2065.10.1007/s13277-015-3998-6Suche in Google Scholar PubMed

Naora, H., Montz, F.J., Chai, C.Y., and Roden, R.B. (2001). Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc. Natl. Acad. Sci. USA 98, 15209–15214.10.1073/pnas.011503998Suche in Google Scholar PubMed PubMed Central

Ota, T., Choi, K.B., Gilks, C.B., Leung, P.C., and Auersperg, N. (2006). Cell type- and stage-specific changes in HOXA7 protein expression in human ovarian folliculogenesis: possible role of GDF-9. Differentiation 74, 1–10.10.1111/j.1432-0436.2006.00053.xSuche in Google Scholar PubMed

Ota, T., Gilks, C.B., Longacre, T., Leung, P.C., and Auersperg, N. (2007). HOXA7 in epithelial ovarian cancer: interrelationships between differentiation and clinical features. Reprod. Sci. 14, 605–614.10.1177/1933719107307781Suche in Google Scholar PubMed

Ozes, A.R., Miller, D.F., Ozes, O.N., Fang, F., Liu, Y., Matei, D., Huang, T., and Nephew, K.P. (2016). NF-kappaB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer. Oncogene 35, 5350–5361.10.1038/onc.2016.75Suche in Google Scholar PubMed PubMed Central

Qiu, J.J., Lin, Y.Y., Ye, L.C., Ding, J.X., Feng, W.W., Jin, H.Y., Zhang, Y., Li, Q., and Hua, K.Q. (2014). Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer. Gynecol. Oncol. 134, 121–128.10.1016/j.ygyno.2014.03.556Suche in Google Scholar PubMed

Qiu, J.J., Wang, Y., Ding, J.X., Jin, H.Y., Yang, G., and Hua, K.Q. (2015). The long non-coding RNA HOTAIR promotes the proliferation of serous ovarian cancer cells through the regulation of cell cycle arrest and apoptosis. Exp. Cell Res. 333, 238–248.10.1016/j.yexcr.2015.03.005Suche in Google Scholar PubMed

Shah, N., Jin, K., Cruz, L.A., Park, S., Sadik, H., Cho, S., Goswami, C.P., Nakshatri, H., Gupta, R., Chang, H.Y., et al. (2013). HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression. Cancer Res. 73, 5449–5458.10.1158/0008-5472.CAN-13-1178Suche in Google Scholar

Siegel, R.L., Miller, K.D., and Jemal, A. (2017). Cancer Statistics, 2017. CA Cancer J. Clin. 67, 7–30.10.3322/caac.21387Suche in Google Scholar

Swisher, E.M., Lin, K.K., Oza, A.M., Scott, C.L., Giordano, H., Sun, J., Konecny, G.E., Coleman, R.L., Tinker, A.V., O’Malley, D.M., et al. (2017). Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. Lancet Oncol. 18, 75–87.10.1016/S1470-2045(16)30559-9Suche in Google Scholar

Tang, B., Qi, G., Sun, X., Tang, F., Yuan, S., Wang, Z., Liang, X., Li, B., Yu, S., Liu, J., et al. (2016). HOXA7 plays a critical role in metastasis of liver cancer associated with activation of Snail. Mol. Cancer 15, 57.10.1186/s12943-016-0540-4Suche in Google Scholar PubMed PubMed Central

Teschendorff, A.E., Lee, S.H., Jones, A., Fiegl, H., Kalwa, M., Wagner, W., Chindera, K., Evans, I., Dubeau, L., Orjalo, A., et al. (2015). HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Med. 7, 108.10.1186/s13073-015-0233-4Suche in Google Scholar PubMed PubMed Central

Troiano, G., Caponio, V.C.A., Boldrup, L., Gu, X., Muzio, L.L., Sgaramella, N., Wang, L., and Nylander, K. (2017). Expression of the long non-coding RNA HOTAIR as a prognostic factor in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncotarget 8, 73029–73036.10.18632/oncotarget.20373Suche in Google Scholar PubMed PubMed Central

Wang, Y., Wang, H., Song, T., Zou, Y., Jiang, J., Fang, L., and Li, P. (2015). HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer. Mol. Med. Rep. 12, 2211–2216.10.3892/mmr.2015.3562Suche in Google Scholar PubMed

Xiao, F., Bai, Y., Chen, Z., Li, Y., Luo, L., Huang, J., Yang, J., Liao, H., and Guo, L. (2014). Downregulation of HOXA1 gene affects small cell lung cancer cell survival and chemoresistance under the regulation of miR-100. Eur. J. Cancer 50, 1541–1554.10.1016/j.ejca.2014.01.024Suche in Google Scholar PubMed

Yang, G., Lu, X., and Yuan, L. (2014). LncRNA: a link between RNA and cancer. Biochim. Biophys. Acta 1839, 1097–1109.10.1016/j.bbagrm.2014.08.012Suche in Google Scholar PubMed

Yiwei, T., Hua, H., Hui, G., Mao, M., and Xiang, L. (2015). HOTAIR interacting with MAPK1 regulates ovarian cancer skov3 cell proliferation, migration, and invasion. Med. Sci. Monit. 21, 1856–1863.10.12659/MSM.893528Suche in Google Scholar PubMed PubMed Central

Yu, X. and Li, Z. (2015). Long non-coding RNA HOTAIR: a novel oncogene. Mol. Med. Rep. 12, 5611–5618.10.3892/mmr.2015.4161Suche in Google Scholar PubMed

Yu, Y., Lv, F., Liang, D., Yang, Q., Zhang, B., Lin, H., Wang, X., Qian, G., Xu, J., and You, W. (2017). HOTAIR may regulate proliferation, apoptosis, migration and invasion of MCF-7 cells through regulating the P53/Akt/JNK signaling pathway. Biomed. Pharmacother. 90, 555–561.10.1016/j.biopha.2017.03.054Suche in Google Scholar PubMed

Zhang, Y., Cheng, J.C., Huang, H.F., and Leung, P.C. (2013). Homeobox A7 stimulates breast cancer cell proliferation by up-regulating estrogen receptor-alpha. Biochem. Biophys. Res. Commun. 440, 652–657.10.1016/j.bbrc.2013.09.121Suche in Google Scholar PubMed

Received: 2017-10-23
Accepted: 2017-12-08
Published Online: 2018-02-19
Published in Print: 2018-04-25

©2018 Walter de Gruyter GmbH, Berlin/Boston

Heruntergeladen am 6.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/hsz-2017-0274/html
Button zum nach oben scrollen